Moreover, simultaneous inhibition of HSF1 and CBS significantly enhances the suppression of prostate cancer cell proliferation and reduces transsulfuration pathway metabolites, underscoring a potent strategy for tackling prostate cancer progression [102]. The gene discussed is HSF1; the disease is prostate carcinoma.